Table 11.
Oncologic outcomes after FST of uterine sarcomas.
| Sarcoma | Patients, n | Recurrences, n (%) | Recurrences during Pregnancy, n | Death, n (%) |
|---|---|---|---|---|
| LG-ESS | 63 | 34 (54) | 3 | 1 (2) |
| Adenosarcoma | 19 | 3 (16) | 0 | 0 |
| STUMP | 84 | 9 (11) | 0 | 1 (1) |
| LMS | 7 | 5 (71) | 1 | 4 (57) |
| UTROSCT | 2 | 0 | 0 | 0 |
| Embryonal RMS of uterine cervix | 35 | 5 (14) | 1 | 0 |
| Total | 210 | 56 (27) | 5 | 6 (3) |
FST: fertility-sparing treatment; LG-ESS: low-grade endometrial stromal sarcoma; LMS: leiomyosarcoma; n: number; RMS: rhabdomyosarcoma; STUMP: smooth muscle tumor of uncertain malignant potential; UTROSCT: uterine tumor resembling ovarian sex cord tumor.